D-Glucopyranosyl-phenyl-substituted cycles of general formula I ##STR00001## wherein the groups R.sup.1 to R.sup.6, Z, Cy and R.sup.7a, R.sup.7b, R.sup.7c, R.sup.7d are defined as in claim 1, have an inhibiting effect on the sodium-dependent glucose cotransporter SGLT. The present invention also relates to pharmaceutical compositions for the treatment of metabolic disorders.